#ESMO21
Thierry Conroy reports on key results from ESMO Congress 2021 on LBA57 - Unicancer GI PRODIGE 24/CCTG PA6 trial: Updated results of a multicenter randomized phase 3 trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients (pts) with resected pancreatic ductal adenocarcinomas.
Produced by the European Society for Medical Oncology
http://oncologypro.esmo.org
![Frightened Rabbit - Backyard Skulls [Official Video]](https://images.mixrolikus.cc/video/bx7dF89a3z4)
